Original Article

You have full text access to this OnlineOpen article

Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy†

  1. Alice B. Kornblith Ph.D.1,‡,*,
  2. James E. Herndon II Ph.D.2,
  3. Raymond B. Weiss M.D.3,
  4. Chunfeng Zhang M.S.2,
  5. Enid L. Zuckerman M.S.W.4,
  6. Sylvia Rosenberg M.S.W.4,
  7. Magriet Mertz Ph.D.5,
  8. David Payne Ph.D.4,
  9. Mary Jane Massie M.D.4,
  10. James F. Holland M.D.6,
  11. Patti Wingate7,
  12. Larry Norton M.D.4,
  13. Jimmie C. Holland M.D.4

Article first published online: 23 JUN 2003

DOI: 10.1002/cncr.11531

Issue

Cancer

Cancer

Volume 98, Issue 4, pages 679–689, 15 August 2003

Additional Information

How to Cite

Kornblith, A. B., Herndon, J. E., Weiss, R. B., Zhang, C., Zuckerman, E. L., Rosenberg, S., Mertz, M., Payne, D., Jane Massie, M., Holland, J. F., Wingate, P., Norton, L. and Holland, J. C. (2003), Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer, 98: 679–689. doi: 10.1002/cncr.11531

Author Information

  1. 1

    Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

  2. 2

    Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, North Carolina

  3. 3

    Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC

  4. 4

    Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York

  5. 5

    Department of Medicine, University of Pretoria, Pretoria, South Africa

  6. 6

    Department of Medicine, Mount Sinai School of Medicine, New York, New York

  7. 7

    Department of Medicine, Memorial Hospital of Rhode Island, Providence, Rhode Island

  1. ‡

    Fax: (617) 632-1930

*Women's Cancers Program, Room D1210, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115

  1. †

    The following institutions participated in this study: Cancer and Leukemia Group B Statistical Office, Durham, NC (Stephen George, Ph.D., supported by CA33601); Dartmouth Medical School–Norris Cotton Cancer Center, Lebanon, NH (Marc Ernstoff, MD, supported by CA04326); Georgetown University Medical Center, Washington, DC (Edward P. Gelmann, M.D., supported by CA77597); Massachussetts General Hospital, Boston, MA (Michael L. Grossbard, M.D., supported by CA12449); Mount Sinai School of Medicine, New York, NY (Lewis Silverman, M.D., supported by CA04457); North Shore–Long Island Jewish Medical Center, Manhasset, NY (Daniel R. Budman, M.D., supported by CA35279); Rhode Island Hospital, Providence, RI (William Sikov, M.D., supported by CA08025); Roswell Park Cancer Institute, Buffalo, NY (Ellis Levine, M.D., supported by CA02599); SUNY Upstate Medical University, Syracuse, NY (Stephen L. Graziano, M.D., supported by CA21060); University of California at San Diego, San Diego, CA (Stephen Seagren, M.D., supported by CA11789); University of Maryland Cancer Center, Baltimore, MD (David Van Echo, M.D., supported by CA31983); University of Pretoria, Pretoria, South Africa; University of Missouri–Ellis Fischel Cancer Center, Columbia, MO (Michael C. Perry, M.D., supported by CA12046); Wake Forest University School of Medicine, Winston-Salem, NC (David D. Hurd, M.D., supported by CA03927); Walter Reed Army Medical Center, Washington, DC (Joseph J. Drabeck, M.D., supported by CA26806); Weill Medical College of Cornell University, New York, NY (Michael Schuster, M.D., supported by CA07968); Western Pennsylvania Cancer Institute, Pittsburgh, PA (Richard K. Shadduck, M.D.).The current study was performed for the Cancer and Leukemia Group B (CALGB), Chicago, IL.

Publication History

  1. Issue published online: 1 AUG 2003
  2. Article first published online: 23 JUN 2003
  3. Manuscript Accepted: 16 APR 2003
  4. Manuscript Revised: 15 APR 2003
  5. Manuscript Received: 10 FEB 2003

Funded by

  • National Cancer Institute. Grant Number: CA31946
  • Cancer and Leukemia Group B (Richard L. Schilsky, M.D., Chairman)
  • T. J. Martell Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (113K)

REFERENCES

  • 1
    Kornblith AB. Psychosocial adaptation of cancer survivors. In: Holland JC. Psycho-oncology. New York: Oxford University Press, 1998: 223–254.
  • 2
    Lasry JCM, Margolese RG, Poisson R, et al. Depression and body image following mastectomy and lumpectomy. J Chronic Dis. 1987; 40: 529–534.
  • 3
    Sneeuw KCA, Aaronson NK, Yarnold JR, et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiother Oncol. 1992; 25: 160–166.
  • 4
    Glanz K, Lerman C. Psychosocial impact of breast cancer: a critical review. Ann Behav Med. 1992; 14: 204–212.
  • 5
    Moyer A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol. 1997; 16: 284–298.
  • 6
    Kiebert GM, de Haes JCJM, van de Velde CJH. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991; 9: 1059–1070.
  • 7
    Weiss RB, Korzun AH, Tormey DC, Holland JF, Rice MA, Wood WC. Adjuvant chemotherapy for breast carcinoma using CMFVP versus CMF versus CMF-MER: the nine year results for patients with 1–3 axillary nodes. In: SalmonSE, JonesSE, editors. Adjuvant therapy for cancer (5th edition). New York: Grune & Stratton, 1987: 327–336.
  • 8
    Kornblith AB, Holland JC. A model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework. J Natl Cancer Inst Monogr. 1996; 20: 55–62.
  • 9
    Kornblith AB, Herndon J, Zuckerman E, et al. Comparison of long-term psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Ann Oncol. 1998; 9: 297–306.
  • 10
    Kornblith AB, Herndon JE, Silverman LR, et al. The impact of 5-azacytidine on the quality of life of patients with the myelodysplastic syndrome (MDS) treated in a randomized Phase III trial of the Cancer and Leukemia Group B (CALGB). J Clin Oncol. 2002; 20: 2441–2452.
  • 11
    Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life of adult leukemia survivors treated on clinical trials of the Cancer and Leukemia Group B from 1971–1988: predictors for later psychological distress. Cancer. 1997; 80: 1936–1944.
    Direct Link:
  • 12
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment for Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365–376.
  • 13
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13: 595–605.
  • 14
    Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Annual Meeting of the International Society for Traumatic Stress Studies; San Antonio, Texas; October 24–27, 1993.
  • 15
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition). Washington DC: American Psychiatric Association, 1994.
  • 16
    Cella DF, Pratt A, Holland JC. Persistent anticipatory nausea, vomiting, and anxiety in cured Hodgkin's disease patients after completion of chemotherapy. Am J Psychiatry. 1986; 143: 641–643.
  • 17
    Kornblith AB, Anderson J, Cella DF, et al. Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation. Cancer. 1992; 70: 2214–2224.
    Direct Link:
  • 18
    Fillenbaum GG. Multidimensional functional assessment of older adults. The Duke older Americans resources and services procedures. Hillsdale, NJ: Lawrence Erlbaum, 1988.
  • 19
    Siegel K, Raveis VH, Mor V, Houts P. The relationship of spousal caregiver burden to patient disease and treatment-related conditions. Ann Oncol. 1991; 2: 511–516.
  • 20
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705–714.
  • 21
    Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978; 46: 932–946.
  • 22
    Davies AR, Ware JE. GHAA's consumer satisfaction survey and user's manual. Washington: Group Health Association of America, 1991.
  • 23
    Holland JC, Herndon J, Kornblith AB, et al. A sociodemographic data collection model for cooperative clinical trials [abstract]. Proc Am Soc Clin Oncol. 1992; 11: 157.
  • 24
    King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996; 5: 555–567.
  • 25
    Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002; 20: 4242–4248.
  • 26
    Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001; 92: 1368–1377.
    Direct Link:
  • 27
    Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999; 17: 143–149.
  • 28
    De Girolamo G, McFarlane AC. The epidemiology of PTSD: a comprehensive review of the international literature. In: MarsellaAJ, FriedmanMJ, GerrityET, ScurfieldRM, editors. Ethnocultural aspects of posttraumatic stress disorder: issues, research and clinical applications. Washington DC: American Psychological Association, 1996: 33–86.
  • 29
    Meyer L, Aspegren K. Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer. Acta Oncol. 1989; 28: 13–18.
  • 30
    Ganz PA, Desmond KA, Relin TR, Meyrowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999; 17: 2371–2380.
  • 31
    Kornblith AB, Herndon JE, Zuckerman E, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001; 91: 443–454.
    Direct Link:
  • 32
    Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996; 88: 812–816.
View Full Article (HTML) Get PDF (113K)